Amanote Research
Register
Sign In
267. Development of a New Strategy for X-CGD Gene Therapy Using a miRNA Regulated Lentiviral Vector
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)36839-3
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2011
Authors
Unknown
Publisher
Elsevier BV
Related search
Dual-Regulated Lentiviral Vector for Gene Therapy of X-Linked Chronic Granulomatosis
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
288. Dual-Regulated Lentiviral Vector for Gene Therapy of X-Linked Chronic Granulomatous Disease
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
316. Integration Site Distribution of Lentiviral Vector in Gene Therapy for X-Adrenoleukodystrophy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Development of Gene Therapy for Hematopoietic Stem Cells Using Lentiviral Vectors
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
A Lentiviral Gene Therapy Strategy for the in Vitro Production of Feline Erythropoietin
PLoS ONE
Multidisciplinary
223. Lentiviral Vector Mediated Gene Therapy for X-Linked Lymphoproliferative Disease Restores Humoral and Cellular Functions
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Robust, Reversible Gene Knockdown Using a Single Lentiviral Short Hairpin RNA Vector
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
531. Designing Trans-Regulated Lentiviral Vectors for Gene Transfer in Functional Genomics and Gene Therapy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Generation of an Optimized Lentiviral Vector Encoding a High-Expression Factor VIII Transgene for Gene Therapy of Hemophilia A
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
